Investigational New Drug

The post-IND clinical trial phase is a critical stage in the investigational new drug (IND) process, ensuring ongoing safety and

The protection of trial participants in the context of Investigational New Drugs is a cornerstone of ethical and legal conduct

The integrity of investigational new drugs (IND) hinges not only on scientific rigor but also on meticulous recordkeeping. Ensuring compliance

Data Monitoring Committees in INDs are pivotal to ensuring the safety and integrity of investigational new drug trials. Their oversight

The use of placebos in Investigational New Drug (IND) trials is a pivotal element in clinical research, raising critical ethical

The regulation of cell and gene therapies is a pivotal aspect shaping the future of personalized medicine and innovative treatments.

Genetic testing has become an integral component of modern drug development, especially within the framework of Investigational New Drug (IND)

The development of biological products presents unique scientific and regulatory challenges, especially within the framework of Investigational New Drug (IND)

Expanded Access and Compassionate Use are critical pathways allowing patients access to investigational new drugs outside of clinical trials, often

The use of investigational drugs outside of clinical trials raises complex legal and ethical questions. Balancing patient access with regulatory